News
Automatically gathered and summarized from longevity-focused publications, with links to the original reporting.
longevity.technology · Sep 9, 2026
Moonwalk Biosciences raises $70m to test new muscle-sparing obesity drug in humans - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.
Read original →longevity.technology · Sep 9, 2026
Genflow meets primary endpoint in SLAB dog trial - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Genflow announced that its SLAB (Sarcopenia and Longevity in Aged Beagles) clinical trial met its primary endpoint.
Read original →longevity.technology · Sep 9, 2026
Sky Labs showcases CART ring-type blood pressure monitor at ESC 2026 - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Sky Labs presented clinical research on its ring-type blood pressure monitor CART at ESC 2026 in Munich.
Read original →longevity.technology · Sep 9, 2026
AlzeCure CEO to present Alzheimer’s progress, Eli Lilly partnership in Stockholm - Longevity.TechnologyLongevity.Technology is a registered trademark of First Longevity Limited. First Longevity Ltd. Registered Office: 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB. Registered in England No.: 12345643 First Logevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest.
Read original →longevity.technology · Sep 9, 2026
UK regulators accept Biosplice's new knee osteoarthritis drug for formal review - Longevity.TechnologyLongevity.Technology is a registered trademark of First Longevity Limited. First Longevity Ltd. Registered Office: 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB. Registered in England No.: 12345643 First Logevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest.
Read original →longevity.technology · Sep 8, 2026
Rentosertib puts aging clocks to the clinical testSix proteomic clocks detect a younger biological age signal in an IPF trial – but separating geroprotection from treatment remains key. Six proteomic clocks, six different research pedigrees, one direction of travel: that is the headline finding of a new study in Nature Biotechnology , and it is arresting enough on its own terms.
Read original →longevity.technology · Sep 8, 2026
Rznomics brings RNA editing into Lilly’s San Diego biotech hubSouth Korean RNA-editing firm enters Eli Lilly’s San Diego innovation hub to speed its precision gene-therapy pipeline toward the clinic. Biotech real estate has its own hierarchy, and San Diego sits near the top.
Read original →longevity.technology · Sep 8, 2026
Lone Korean biotech nears $81m antiaging prizePRGS&Tech is South Korea’s only team left in XPRIZE Healthspan’s $110 million race to prove a drug can help everyone age more slowly. Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees .
Read original →longevity.technology · Sep 8, 2026
New ALS drug data reveal a mitochondrial fixNRG Therapeutics unpacks the molecular switch behind its ALS drug candidate, adding fresh mechanistic evidence to a trial already underway. Longevity.Technology has been following NRG5051 since the earliest days of its preclinical story, through a Parkinson’s UK partnership, a $68.1 million (£50 million) Series B and, this January, the dosing of its first clinical trial volunteers .
Read original →longevity.technology · Sep 8, 2026
Biograph builds dedicated women’s preventive health armThe preventive-care clinic adds hormone testing, menopause care and longitudinal risk tracking built specifically around female biology. Ask most women what their annual physical covers, and you’ll get some version of the same answer: not much, and definitely not menopause.
Read original →lifespan.io · Sep 8, 2026
Late-Life GLP-1 Treatment Increases Lifespan in Female MiceIn a new study, semaglutide given late in life increased median lifespan in female mice by more than 12% and improved various health markers. Semaglutide’s effect possibly went beyond caloric restriction [1].
Read original →longevity.technology · Sep 8, 2026
Longevity.Technology wants to make longevity make senseA new 10–15 minute series aims to bring clarity and nuance to the big and bold ideas shaping the future of human longevity. Longevity.Technology has launched Longevity Bites , a new segment running alongside its flagship podcast, Longevity.Technology UNLOCKED . The format is simple on paper: ten to fifteen minutes, one topic, explained properly.
Read original →longevity.technology · Sep 8, 2026
Rznomics publishes new method to improve circular RNA manufacturing for vaccines, gene therapies - Longevity.TechnologyLongevity.Technology is a registered trademark of First Longevity Limited. First Longevity Ltd. Registered Office: 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB. Registered in England No.: 12345643 First Logevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest.
Read original →longevity.technology · Sep 8, 2026
Genflow Biosciences trial meets primary endpoint in aged dogs - Longevity.TechnologyLongevity.Technology is a registered trademark of First Longevity Limited. First Longevity Ltd. Registered Office: 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB. Registered in England No.: 12345643 First Logevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest.
Read original →longevity.technology · Sep 8, 2026
Insilico AI candidate rentosertib reverses proteomic aging clocks - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Insilico Medicine published a study in Nature Biotechnology reporting that its AI-designed idiopathic pulmonary fibrosis candidate rentosertib produced reductions in predicted biological age.
Read original →lifespan.io · Sep 7, 2026
Mice With Growth Hormone Halted in Middle Age Live LongerResearchers publishing in Aging Cell have described how stopping growth hormone receptor production in midlife significantly lengthens the lives of mice . Growth but diabetes Growth hormone affects the metabolism of fats (lipids), increasing the levels of circulating fatty acids while increasing insulin-like growth factor 1 (IGF-1) and impairing the function of insulin itself [1].
Read original →longevity.technology · Sep 7, 2026
Amprion expands Parkinson’s test to EuropeLicensing deal brings Amprion’s misfolded-protein test closer to European trial sites, aiming to speed up neurodegenerative drug development. Long before a patient ever shows a tremor, Parkinson’s disease may already be rewriting the biology of their brain.
Read original →longevity.technology · Sep 7, 2026
Celularity lands $300m MuseCell manufacturing dealDeal with Singapore’s MuseCell Innovations could bring $300 million in business and 200 jobs to Celularity’s cell platform. Deals in cell therapy tend to get announced in two flavors: the kind built around a single drug, and the kind built around infrastructure. This unglamorous plumbing decides whether any of these therapies can actually be made at scale.
Read original →longevity.technology · Sep 7, 2026
Longeveron to present cell therapy progress at HC Wainwright conference - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Longeveron will present at the H.C.
Read original →longevity.technology · Sep 7, 2026
Daewoong wins US patent nod for antiaging mRNAA newly allowed US patent covers the lipid delivery system behind Daewoong’s experimental mRNA platform for reprogramming aged cells. Patents rarely make for thrilling headlines. They’re procedural, often years behind the science they protect, and written in language designed to be as dry as legally possible.
Read original →longevity.technology · Sep 7, 2026
Longevica hires drug-approval veteran as CEOFresh off the world’s largest mammalian longevity screen, Longevica names ex-Genentech exec Prasun Mishra to steer science toward the clinic. Longevica Therapeutics has spent the past four years and $13 million running mice through their entire lives to find drugs that might extend ours.
Read original →longevity.technology · Sep 7, 2026
iBio to showcase AI-driven antibody pipeline at Wells Fargo Healthcare Conference - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: iBio will participate in the Wells Fargo 21st Annual Healthcare Conference in Boston, 8-10 September 2026.
Read original →fightaging.org · Sep 5, 2026
Fight Aging! Newsletter, September 6th 2026Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe to the newsletter, please visit: https://www.fightaging.org/newsletter/ .
Read original →longevity.technology · Sep 4, 2026
Pig kidneys just bought humans extra years in eGenesis studyOne patient spent nine months off dialysis with a genetically engineered pig kidney before successfully receiving a human transplant. More than 800,000 Americans live with end-stage kidney disease, and the gap between who needs a transplant and who can get one has only widened. Just 28,000 kidney transplants were performed in the U.S. in 2024, a fraction of what’s needed.
Read original →longevity.technology · Sep 4, 2026
UK elder-care model targets Asia’s aging boomVHH brings its ‘village’ model to Malaysia, betting that longevity gains only pay off economically if care reaches everyone. Ask most people what caring for an aging population looks like, and they’ll picture a nursing home: a building you move into when you can no longer live independently, cut off from the life you had before.
Read original →longevity.technology · Sep 4, 2026
Function connects your lab results to the AI health chatbot you useFunction Health now lets members feed lab results into ChatGPT, Claude and Perplexity, turning AI answers into ones grounded in biology. Millions of people already type their symptoms into an AI chatbot before they type them into a search bar for a doctor’s office. It’s fast, free and available at 2 a.m. when the worry hits hardest.
Read original →longevity.technology · Sep 4, 2026
HCW Biologics wins key U.S. patent protection for hair loss drug - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: HCW Biologics received a Notice of Allowance from the U.S. Patent and Trademark Office for claims directed to the use of HCW9302 to treat alopecia areata. Together with four recently issued U.S. patents (Nos.
Read original →longevity.technology · Sep 4, 2026
Scribe Therapeutics starts first human trial for cholesterol-lowering gene therapy - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Scribe Therapeutics reported second-quarter 2026 financial results and pipeline progress.
Read original →longevity.technology · Sep 4, 2026
Rapalogix Health opens Princeton laboratory to advance skin longevity research - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Rapalogix Health has established a dedicated research laboratory at Princeton Innovation Center BioLabs in Princeton, New Jersey.
Read original →longevity.technology · Sep 4, 2026
China approves Leqembi subcutaneous autoinjector for early Alzheimer’s - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.
Read original →longevity.technology · Sep 4, 2026
FibroBiologics granted US patent for fibroblast wound therapy - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: FibroBiologics, a Houston-based clinical-stage biotechnology company, announced that the United States Patent and Trademark Office issued U.S. Patent No.
Read original →longevity.technology · Sep 4, 2026
Mito Health passes one million tests, expands preventive offerings - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Mito Health has expanded its direct-to-consumer diagnostics marketplace into seven categories of preventive testing and, according to the company, has run more than one million lab tests.
Read original →longevity.technology · Sep 4, 2026
Insilico Medicine included in HKEX Tech 100 Index - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.
Read original →lifespan.io · Sep 3, 2026
The Last Generation to Die: Interview With Tim MaupinFilmmaker Tim Maupin has spent a number of years developing The Last Generation to Die , a near-future film about what happens when the first true rejuvenation technologies arrive and who gets left behind. The project has now reached the top 65 of the Future Vision XPrize , a global contest seeking optimistic visions of humanity’s future.
Read original →longevity.technology · Sep 3, 2026
LifespanningRx launches peptide explorer for clinician-guided reviews - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: LifespanningRx has launched the Peptide Explorer, an online educational tool designed to help users organize health goals and explore up to three peptide therapy candidates before clinical evaluation.
Read original →longevity.technology · Sep 3, 2026
Minicircle named XPRIZE Healthspan finalist - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Minicircle was named one of 10 finalists in the seven-year, $101 million XPRIZE Healthspan competition, placing the Austin, Texas gene therapy developer among contenders seeking measurable rejuvenation in adults aged 50 to 80.
Read original →longevity.technology · Sep 3, 2026
United Therapeutics seeks FDA approval for inhaled treatment for idiopathic pulmonary fibrosis - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: According to United Therapeutics, the U.S.
Read original →lifespan.io · Sep 2, 2026
Invested in Her Campaign Extends Fundraising DeadlineDriven by ongoing support from their community, The Longevity Science Foundation is extending the deadline for the Invested in Her campaign to October 1, 2026, as they work toward a $250,000 fundraising target to support early-stage research into ovarian aging and menopause. Hundreds of millions of women live longer than men yet spend more years in poor health.
Read original →fightaging.org · Sep 2, 2026
Socioeconomic and Demographic Differences Have Little Effect on Human LongevitySeptember 9th, 2026 Past research has noted that socioeconomic status is a part of a web of correlations that include wealth , intelligence , education , lifestyle choices, and longevity. Untangling all of that to make definitive pronouncements on what exactly drives the observed variation in human life span has proven challenging.
Read original →fightaging.org · Sep 2, 2026
Automation of Screening Studies for Compounds that Slow Aging is Becoming More AmbitiousSeptember 9th, 2026 Screening compound libraries for effects on aging in short-lived species has grown to become a significant area of interest in the aging research community.
Read original →longevity.technology · Sep 2, 2026
Exonate rebrands as Foventa Therapeutics to advance diabetic eye drop therapy - Longevity.TechnologyLongevity.Technology is a registered trademark of First Longevity Limited. First Longevity Ltd. Registered Office: 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB. Registered in England No.: 12345643 First Logevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest.
Read original →longevity.technology · Sep 2, 2026
NorthStrive expands AI program with Yuva to nominate cardiac leads - Longevity.TechnologyLongevity.Technology is a registered trademark of First Longevity Limited. First Longevity Ltd. Registered Office: 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB. Registered in England No.: 12345643 First Logevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest.
Read original →longevity.technology · Sep 2, 2026
Resolution Therapeutics, BCA partner to expand access to experimental liver disease therapy - Longevity.TechnologyLongevity.Technology is a registered trademark of First Longevity Limited. First Longevity Ltd. Registered Office: 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB. Registered in England No.: 12345643 First Logevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest.
Read original →longevity.technology · Sep 2, 2026
Oligomerix appoints new interim CEO to advance Alzheimer’s drug pipeline - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Oligomerix appointed Cara Cassino, M.D., as interim president and chief executive officer on 31 August 2026.
Read original →fightaging.org · Sep 1, 2026
The Adaptive Cost Hypothesis of Aging, a Viewpoint on Antagonist PleiotropySeptember 8th, 2026 At the high level, without delving into specific mechanisms, the consensus view on aging is that it exists in the shadow of natural selection . The selection pressure that drives the spread of changes in genes, systems, biology in general in any given species operates most strongly on early life reproductive success.
Read original →lifespan.io · Sep 1, 2026
Rejuvenation Roundup August 2026Properly untangling aging means untangling its various counterbalances, sometimes on the individual level. Here’s what’s been investigated this month. Interviews Wei-Wu He: People Should Become the CEOs of Their Own Health : Wei-Wu He is an unusual combination of scientist and businessman, and his current company focuses on using precision medicine to lengthen people’s lives.
Read original →fightaging.org · Sep 1, 2026
Dogs Exhibit Comorbidity and Mortality Risk in Much the Same Way as HumansSeptember 8th, 2026 One of the goals of the Dog Aging Project is to better establish that the characteristics of aging in dogs are close enough to the characteristics of aging in humans to make the results of interventions on dog life span relevant to the development of human medicine.
Read original →fightaging.org · Sep 1, 2026
Age Acceleration in Various Proteomic Clocks Correlates with Risk of Mortality and Age-Related DiseaseSeptember 8th, 2026 In recent years, researchers have been gathering as much data as possible on the behavior of aging clocks of various sorts. The study here is an example of the type, in which multiple proteomic clocks were assessed in large epidemiological study populations.
Read original →longevity.technology · Sep 1, 2026
Canada recommends public funding for Alzheimer's drug Leqembi - Longevity.TechnologyLongevity.Technology is a registered trademark of First Longevity Limited. First Longevity Ltd. Registered Office: 2 Communications Road, Greenham Business Park, Newbury, Berkshire, RG19 6AB. Registered in England No.: 12345643 First Logevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest.
Read original →longevity.technology · Sep 1, 2026
Oligomerix appoints new interim CEO to lead Alzheimer's drug development - Longevity.TechnologyLongevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: Oligomerix has appointed Dr. Cara Cassino as interim president and chief executive officer as the privately held biotech moves from discovery toward clinical development of its lead Alzheimer’s candidate.
Read original →